ASPIRATION PLEURAL CAVITY side effect
What is ASPIRATION PLEURAL CAVITY ?Drugs associated with ASPIRATION PLEURAL CAVITY
ADDERALL CEREZYME CYCLOSPORINE DECADRON ESTRADERM GLEEVEC IMATINIB LETROZOLE MYCOPHENOLATE ZOMETAASPIRATION PLEURAL CAVITY : Cyclosporine Side Effects Report #5646672-5
Health Professional from BRAZIL reported CYCLOSPORINE problem on Feb 19, 2008. Female patient, 67 years of age, was diagnosed with renal transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, dyspnoea, epstein-barr virus infection, human herpesvirus 8 infection, pleural effusion, primary effusion lymphoma, . CYCLOSPORINE dosage: 100 MG/DAY. During the same period patient was treated with AZATHIOPRINE, PREDNISONE, RAPAMYCIN. Patient died.
ASPIRATION PLEURAL CAVITY : Mycophenolate Side Effects Report #5645817-0
MYCOPHENOLATE MOFETIL problem was reported by a Physician from UNITED STATES on Feb 22, 2008. Male patient, 56 years of age, weighting 189.6 lb, was diagnosed with heart transplant and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, blood albumin decreased, blood creatinine increased, dyspnoea, fluid overload, hypoalbuminaemia, oedema peripheral, . MYCOPHENOLATE MOFETIL dosage: 0.25 MG, BID. During the same period patient was treated with BACTRIM, PROTONIX, PRAVACHOL, VICODIN, NEORAL, PREDNISONE, HYDROCHLOROTHIAZIDE, BUMEX. Patient was hospitalized. Patient recovered.
ASPIRATION PLEURAL CAVITY : Imatinib Side Effects Report #5581324-1
Physician from NETHERLANDS reported IMATINIB problem on Dec 27, 2007. Female patient, 54 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, blood potassium decreased, blood sodium increased, body temperature increased, confusional state, dehydration, fluid retention, hypernatraemia, infection, . IMATINIB dosage: 800 MG, BID. During the same period patient was treated with FUROSEMIDE, DARBEPOETIN ALFA, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.
ASPIRATION PLEURAL CAVITY : Gleevec Side Effects Report #5562814-4
GLEEVEC problem was reported by a Physician from UNITED STATES on Dec 11, 2007. Female patient, 60 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, cellulitis, clostridial infection, delirium, diarrhoea, dyspnoea, erythema, haematuria, . GLEEVEC dosage: 400MG. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient died on 12/10/2007.
ASPIRATION PLEURAL CAVITY : Gleevec Side Effects Report #5564358-2
Physician from UNITED STATES reported GLEEVEC problem on Dec 12, 2007. Female patient, 60 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, cellulitis, clostridial infection, delirium, diarrhoea, dyspnoea, erythema, haematuria, haemoglobin decreased, . GLEEVEC dosage: 400MG. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient died on 12/10/2007.
ASPIRATION PLEURAL CAVITY : Mycophenolate Side Effects Report #5565941-0
MYCOPHENOLATE MOFETIL problem was reported by a Physician from UNITED STATES on Dec 11, 2007. Male patient, 67 years of age, weighting 207.2 lb, was diagnosed with heart transplant and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, atrial fibrillation, blood albumin decreased, calculus ureteric, cardioversion, dyspnoea, fluid overload, gastrooesophageal reflux disease, hiatus hernia, . MYCOPHENOLATE MOFETIL dosage: 0.75 MG, BID. During the same period patient was treated with NEORAL, ANTITHYMOCYTE IMMUNOGLOBULIN, PREDNISONE. Patient was hospitalized. Patient recovered.
ASPIRATION PLEURAL CAVITY : Adderall Side Effects Report #5504845-6
Health Professional from UNITED STATES reported ADDERALL problem on Oct 25, 2007. Female patient, 79 years of age, was diagnosed with schizoaffective disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, dyspnoea, emphysema, oedema peripheral, pulmonary oedema, . ADDERALL dosage: unknown. During the same period patient was treated with PROVIGIL, DEPAKOTE, EFFEXOR, WELLBUTRIN, CLOZARIL. Patient was hospitalized. Patient recovered.
ASPIRATION PLEURAL CAVITY : Mycophenolate Side Effects Report #5506171-8
MYCOPHENOLATE MOFETIL problem was reported by a Physician from UNITED STATES on Oct 25, 2007. Male patient, 56 years of age, weighting 189.6 lb, was diagnosed with heart transplant and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, blood albumin decreased, blood creatinine increased, dyspnoea, fluid overload, hypoalbuminaemia, oedema peripheral, pericardial effusion, pleural effusion, . MYCOPHENOLATE MOFETIL dosage: 0.25 MG, BID. During the same period patient was treated with BACTRIM, PROTONIX, PRAVACHOL, VICODIN, NEORAL, PREDNISONE, HYDROCHLOROTHIAZIDE, BUMEX. Patient was hospitalized. Patient recovered.
ASPIRATION PLEURAL CAVITY : Adderall Side Effects Report #5517953-0
Health Professional from UNITED STATES reported ADDERALL problem on Nov 12, 2007. Female patient, 59 years of age, was diagnosed with schizoaffective disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, dyspnoea, emphysema, oedema peripheral, pleural effusion, . ADDERALL dosage: unknown. During the same period patient was treated with PROVIGIL, DEPAKOTE, EFFEXOR, WELLBUTRIN, CLOZARIL. Patient was hospitalized. Patient died on 11/04/2007.
ASPIRATION PLEURAL CAVITY : Estraderm Side Effects Report #5530102-8
ESTRADERM problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 26, 2007. Female patient, 67 years of age, was diagnosed with menopausal symptoms and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, biopsy breast abnormal, breast cancer, breast cancer in situ, breast reconstruction, cholelithiasis, culdoplasty, dyspnoea, haemangioma of liver, . ESTRADERM dosage: 0.05 MG/DAY, TIWCE WEEKLY. During the same period patient was treated with PROVERA, PREMPRO, PREMARIN, ESTRACE. Patient recovered.
ASPIRATION PLEURAL CAVITY : Imatinib Side Effects Report #5492781-3
Physician from NETHERLANDS reported IMATINIB problem on Oct 12, 2007. Female patient, 54 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, blood potassium decreased, blood sodium increased, body temperature increased, confusional state, dehydration, fluid retention, hypernatraemia, infection, . IMATINIB dosage: 800 MG, BID. During the same period patient was treated with FUROSEMIDE, DARBEPOETIN ALFA, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.
ASPIRATION PLEURAL CAVITY : Letrozole Side Effects Report #5452660-4
LETROZOLE problem was reported by a Physician from UNITED KINGDOM on Sept 12, 2007. Female patient, 70 years of age, was diagnosed with breast cancer metastatic and was treated with LETROZOLE. After drug was administered, patient experienced the following problems/side effects: aspiration pleural cavity, atrial fibrillation, breath sounds abnormal, dyspnoea, heart rate irregular, malignant neoplasm progression, pericardial effusion, pleural effusion, pyrexia, . LETROZOLE dosage: 2.5 MG, QD. Patient was hospitalized. Patient recovered.
ASPIRATION PLEURAL CAVITY : Adderall Side Effects Report #5623070-1
Health Professional from UNITED STATES reported ADDERALL problem on Feb 08, 2008. Female patient, 59 years of age, weighting 186.0 lb, was diagnosed with schizoaffective disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: appendicectomy, aspiration pleural cavity, chest pain, cough, dyspnoea, emphysema, fatigue, hypertension, hypoxia, . ADDERALL dosage: 20 MG, QD. During the same period patient was treated with PROVIGIL, DEPAKOTE, EFFEXOR, WELLBUTRIN, CLOZARIL, SPIRIVA. Patient was hospitalized. Patient died on 11/04/2007.
ASPIRATION PLEURAL CAVITY : Adderall Side Effects Report #5623088-9
ADDERALL problem was reported by a Health Professional from UNITED STATES on Feb 08, 2008. Female patient, 59 years of age, weighting 186.0 lb, was diagnosed with schizoaffective disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: appendicectomy, aspiration pleural cavity, chest pain, cough, dyspnoea, emphysema, fatigue, hypertension, hypoxia, . ADDERALL dosage: 20 MG, QD. During the same period patient was treated with PROVIGIL, DEPAKOTE, EFFEXOR, WELLBUTRIN, CLOZARIL, SPIRIVA. Patient was hospitalized. Patient died on 11/04/2007.
ASPIRATION PLEURAL CAVITY : Cerezyme Side Effects Report #5635688-0
Physician from MEXICO reported CEREZYME problem on Feb 07, 2008. Male patient, 16 years of age, weighting 88.18 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: ascites, aspiration pleural cavity, hepatocellular injury, hypoalbuminaemia, pericardial effusion, pleural effusion, . CEREZYME dosage: unknown. Patient was hospitalized. Patient died on 02/09/2008.
ASPIRATION PLEURAL CAVITY : Decadron Side Effects Report #5582961-0
DECADRON # problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Female patient, 52 years of age, weighting 178.0 lb, was diagnosed with metastases to bone and was treated with DECADRON #. After drug was administered, patient experienced the following problems/side effects: anaemia, angiopathy, aspiration pleural cavity, atelectasis, bone disorder, bone scan abnormal, breast cancer, cardiomyopathy, debridement, . DECADRON # dosage: 10 MG, UNK. During the same period patient was treated with ARANESP, XELODA, MITOXANTRONE, COUMADIN, ADALAT, DIOVAN, ZOLOFT. Patient was hospitalized. Patient died.
ASPIRATION PLEURAL CAVITY : Zometa Side Effects Report #5609288-2
Consumer or non-health professional from UNITED STATES reported ZOMETA problem on Jan 22, 2008. Male patient, 76 years of age, weighting 210.0 lb, was diagnosed with metastases to bone, prostate cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: anaemia, anxiety, aspiration pleural cavity, back pain, bone fistula, bone fragmentation, bone neoplasm, cardiac failure congestive, cataract, . ZOMETA dosage: unknown. During the same period patient was treated with TAXOL, PREDNISONE, DIGITEK, LEXAPRO, MENEST, DYAZIDE, CASODEX. Patient was hospitalized. Patient recovered.
ASPIRATION PLEURAL CAVITY : Zometa Side Effects Report #5565930-6
ZOMETA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 10, 2007. Male patient, 76 years of age, was diagnosed with resorption bone increased, prostate cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: anaemia, anxiety, aspiration pleural cavity, gastrooesophageal reflux disease, hypotension, injury, nervous system disorder, orthostatic intolerance, osteonecrosis, . ZOMETA dosage: unknown. During the same period patient was treated with TAXOL, PREDNISONE, DIGITEK, LEXAPRO, MENEST, DYAZIDE. Patient was hospitalized. Patient recovered.
ASPIRATION PLEURAL CAVITY : Decadron Side Effects Report #5385037-0
Consumer or non-health professional from UNITED STATES reported DECADRON # problem on July 09, 2007. Female patient, 52 years of age, weighting 178.0 lb, was diagnosed with metastases to bone and was treated with DECADRON #. After drug was administered, patient experienced the following problems/side effects: anaemia, angiopathy, aspiration pleural cavity, atelectasis, bone disorder, bone scan abnormal, cardiomyopathy, deep vein thrombosis, . DECADRON # dosage: 10 MG, UNK. During the same period patient was treated with ARANESP, XELODA, MITOXANTRONE, COUMADIN, ADALAT, DIOVAN, ZOLOFT. Patient was hospitalized. Patient died.
ASPIRATION PLEURAL CAVITY : Decadron Side Effects Report #5385037-0
DECADRON # problem was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Female patient, 52 years of age, weighting 178.0 lb, was diagnosed with metastases to bone and was treated with DECADRON #. After drug was administered, patient experienced the following problems/side effects: anaemia, angiopathy, aspiration pleural cavity, atelectasis, bone disorder, bone scan abnormal, cardiomyopathy, deep vein thrombosis, . DECADRON # dosage: 10 MG, UNK. During the same period patient was treated with ARANESP, XELODA, MITOXANTRONE, COUMADIN, ADALAT, DIOVAN, ZOLOFT. Patient was hospitalized. Patient died.